Barbara Kollmeyer is based in Madrid, where she leads MarketWatch's pre-markets coverage of financial markets and writes the Need to Know column. She has worked in London and Los Angeles for MarketWatch previously. Follow her on Twitter @bkollmeyer.
A rout in shares of The Trade Desk has drawn some buyers from the woodwork, specifically Cathie Wood’s flagship ARK Innovation Fund that has dropped money on the ad-technology group for the first time.
The ARKK ARKK fund spent $34 million on 543,000 shares in Trade Desk TTD, -16.66%, according to a trading update that published on Saturday. That stock tumbled 16% on Friday after a September-quarter earnings report revealed a deeply disappointing outlook. According to FactSet, Trade Desk has only missed its revenue forecast one other time in the past five years.
In the wake of its dismal results, analysts were divided on whether the subsequent stock rout was an opportunity or a red flag over investing in advertising-exposed names for the holiday season. Trade Desk was also bought by the ARK Next Generation internet exchange-traded fund ARKW — $4 million for 69,000 shares. That fund has been a regular buyer of the company since June, which marked the first time it bought shares since selling in the latter half of 2021.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ark: Survival Ascended's Xbox & PS5 Versions Are Worth Waiting ForArk: Survival Ascended has seen some extra delays to its release on consoles, but now isn't the time to get impatient in the final stretch.
Read more »
Stock-market rally faces make-or-break moment. How to play U.S. October inflation data.Joseph Adinolfi is a markets reporter at MarketWatch.
Read more »
October CPI Report Could Be a Critical Catalyst for StocksJoseph Adinolfi is a markets reporter at MarketWatch.
Read more »
Dr. Daniel Skovronsky Believes Alzheimer's Disease Treatment Breakthrough is ImminentIn this interview, Dr. Daniel Skovronsky tells MarketWatch what the market is missing about Lilly–and what might be the GLP-1 drugs of the future–as he takes a spot on the MarketWatch 50 list of the most influential people in markets.
Read more »
China may end long-running suspension of Boeing 737 Max aircraft: reportBarbara Kollmeyer is based in Madrid, where she leads MarketWatch's pre-markets coverage of financial markets and writes the Need to Know column. She has worked in London and Los Angeles for MarketWatch previously. Follow her on Twitter bkollmeyer.
Read more »
Micron Technology being sued by China’s Yangtze Memory Technologies over patent infringementBarbara Kollmeyer is based in Madrid, where she leads MarketWatch's pre-markets coverage of financial markets and writes the Need to Know column. She has worked in London and Los Angeles for MarketWatch previously. Follow her on Twitter bkollmeyer.
Read more »